|
G |
BAK1 |
BCL2 antagonist/killer 1 |
multiple interactions |
EXP |
Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of BAK1 protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of BAK1 protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of BAK1 protein] |
CTD |
PMID:26607349 |
|
NCBI chr 7:29,808,849...29,815,345
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions affects expression |
EXP |
Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of BAX protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of BAX protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of BAX protein] Sodium Selenite affects the expression of BAX mRNA |
CTD |
PMID:17342738 PMID:26607349 |
|
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,140
|
|
G |
BCL2L1 |
BCL2 like 1 |
affects expression |
EXP |
Sodium Selenite affects the expression of BCL2L1 mRNA |
CTD |
PMID:17342738 |
|
NCBI chr17:35,366,139...35,415,798
Ensembl chr17:35,366,143...35,414,694
|
|
G |
CASP3 |
caspase 3 |
multiple interactions decreases expression |
EXP |
Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP3 protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of CASP3 protein]; Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of CASP3 protein] Sodium Selenite results in decreased expression of CASP3 protein |
CTD |
PMID:15191356 PMID:17342738 PMID:26607349 |
|
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
|
|
G |
CASP9 |
caspase 9 |
multiple interactions |
EXP |
Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP9 protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of CASP9 protein] |
CTD |
PMID:26607349 |
|
NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007
|
|
G |
GPX4 |
glutathione peroxidase 4 |
increases activity |
EXP |
Sodium Selenite results in increased activity of GPX4 protein |
CTD |
PMID:10998458 |
|
NCBI chr 2:77,321,568...77,323,931
Ensembl chr 2:77,320,464...77,323,931
|
|
G |
KDSR |
3-ketodihydrosphingosine reductase |
multiple interactions |
EXP |
Sodium Selenite inhibits the reaction [Cadmium Chloride promotes the reaction [MIR125A mRNA mutant form results in decreased expression of BCL2 protein]]; Sodium Selenite inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in decreased expression of BCL2 protein] |
CTD |
PMID:26607349 |
|
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
increases expression |
EXP |
Sodium Selenite results in increased expression of MAPK1 protein |
CTD |
PMID:17342738 |
|
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
increases expression |
EXP |
Sodium Selenite results in increased expression of MAPK3 protein |
CTD |
PMID:17342738 |
|
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
|
|
G |
MIR125A |
microRNA mir-125a |
multiple interactions |
EXP |
Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of BAK1 protein]; Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of BAX protein]; Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP3 protein]; Sodium Selenite inhibits the reaction [[Cadmium Chloride co-treated with MIR125A mRNA mutant form] results in increased expression of CASP9 protein]; Sodium Selenite inhibits the reaction [Cadmium Chloride promotes the reaction [MIR125A mRNA mutant form results in decreased expression of BCL2 protein]]; Sodium Selenite inhibits the reaction [Cadmium results in decreased expression of MIR125A mRNA]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in decreased expression of BCL2 protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of BAK1 protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of BAX protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of CASP3 protein]; Sodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in increased expression of CASP9 protein] |
CTD |
PMID:26607349 |
|
NCBI chr 6:58,331,566...58,331,645
Ensembl chr 6:58,331,566...58,331,645
|
|
G |
POMC |
proopiomelanocortin |
multiple interactions |
EXP |
Ditiocarb promotes the reaction [Sodium Selenite inhibits the reaction [POMC protein results in increased secretion of Hydrocortisone]]; Sodium Selenite inhibits the reaction [POMC protein results in increased secretion of Hydrocortisone] |
CTD |
PMID:21466817 |
|
NCBI chr 3:113,661,712...113,668,558
Ensembl chr 3:113,661,004...113,670,418
|
|
|
G |
ACACA |
acetyl-CoA carboxylase alpha |
increases expression multiple interactions |
EXP |
Sodium Glutamate results in increased expression of ACACA mRNA Dietary Fats inhibits the reaction [Sodium Glutamate results in increased expression of ACACA mRNA] |
CTD |
PMID:31360149 |
|
NCBI chr12:38,580,916...38,875,067
Ensembl chr12:38,581,457...38,824,712
|
|
G |
ACOX1 |
acyl-CoA oxidase 1 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of ACOX1 mRNA |
CTD |
PMID:31360149 |
|
NCBI chr12:5,450,913...5,479,550
Ensembl chr12:5,439,361...5,479,546
|
|
G |
FASN |
fatty acid synthase |
multiple interactions increases expression |
EXP |
Dietary Fats inhibits the reaction [Sodium Glutamate results in increased expression of FASN mRNA] |
CTD |
PMID:31360149 |
|
NCBI chr12:922,405...937,560
Ensembl chr12:920,509...937,561
|
|
G |
FFAR2 |
free fatty acid receptor 2 |
multiple interactions affects expression |
EXP |
Dietary Fats affects the reaction [Sodium Glutamate affects the expression of FFAR2 mRNA]; Sodium Glutamate affects the reaction [Dietary Fats affects the expression of FFAR2 mRNA] |
CTD |
PMID:31360149 |
|
NCBI chr 6:44,899,879...44,904,461
Ensembl chr 6:44,901,159...44,904,459
|
|
G |
FFAR4 |
free fatty acid receptor 4 |
affects expression multiple interactions |
EXP |
Sodium Glutamate affects the expression of FFAR4 mRNA Dietary Fats affects the reaction [Sodium Glutamate affects the expression of FFAR4 mRNA]; Sodium Glutamate affects the reaction [Dietary Fats affects the expression of FFAR4 mRNA] |
CTD |
PMID:31360149 |
|
Ensembl chr14:105,011,942...105,037,498
|
|
G |
GPR119 |
G protein-coupled receptor 119 |
affects expression multiple interactions |
EXP |
Sodium Glutamate affects the expression of GPR119 mRNA Dietary Fats affects the reaction [Sodium Glutamate affects the expression of GPR119 mRNA]; Sodium Glutamate affects the reaction [Dietary Fats affects the expression of GPR119 mRNA] |
CTD |
PMID:31360149 |
|
NCBI chr X:106,872,225...106,873,299
Ensembl chr X:106,872,225...106,873,299
|
|
G |
LOC110255234 |
liver carboxylesterase-like |
multiple interactions |
EXP |
Sodium Glutamate inhibits the reaction [Dietary Fats results in decreased expression of CES1 mRNA] |
CTD |
PMID:31360149 |
|
|
|
G |
PNPLA2 |
patatin like phospholipase domain containing 2 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of PNPLA2 mRNA |
CTD |
PMID:31360149 |
|
NCBI chr 2:513,065...517,962
Ensembl chr 2:513,077...518,182
|
|
G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions increases expression |
EXP |
Dietary Fats inhibits the reaction [Sodium Glutamate results in increased expression of SREBF1 mRNA] |
CTD |
PMID:31360149 |
|
NCBI chr12:60,733,967...60,750,951
Ensembl chr12:60,733,907...60,751,267
|
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
increases degradation multiple interactions decreases expression |
EXP |
sodium arsenite results in increased degradation of AKT1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sodium arsenite results in increased degradation of AKT1 protein]; sodium arsenite results in decreased expression of and results in increased phosphorylation of AKT1 protein; Wortmannin inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein] sodium arsenite results in decreased expression of AKT1 protein |
CTD |
PMID:12760830 PMID:16239170 |
|
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
multiple interactions increases expression |
EXP |
bisindolylmaleimide I inhibits the reaction [sodium arsenite results in increased expression of HIF1A mRNA]; Go 6976 inhibits the reaction [sodium arsenite results in increased expression of HIF1A mRNA] sodium arsenite results in increased expression of HIF1A mRNA; sodium arsenite results in increased expression of HIF1A protein |
CTD |
PMID:15089098 |
|
NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845
|
|
G |
MAPK6 |
mitogen-activated protein kinase 6 |
increases expression |
EXP |
sodium arsenite results in increased expression of MAPK6 protein |
CTD |
PMID:12760830 |
|
NCBI chr 1:119,725,026...119,770,988
Ensembl chr 1:119,725,029...119,771,312
|
|
G |
NOS3 |
nitric oxide synthase 3 |
multiple interactions increases degradation decreases expression |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased phosphorylation of NOS3 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sodium arsenite results in increased degradation of NOS3 protein]; sodium arsenite results in increased phosphorylation of and results in decreased activity of NOS3 protein; Wortmannin inhibits the reaction [sodium arsenite results in increased phosphorylation of NOS3 protein] sodium arsenite results in decreased expression of NOS3 protein |
CTD |
PMID:16239170 |
|
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
|
|
G |
PRKACA |
protein kinase cAMP-activated catalytic subunit alpha |
decreases expression |
EXP |
sodium arsenite results in decreased expression of PRKACA protein |
CTD |
PMID:12760830 |
|
NCBI chr 2:65,074,876...65,095,564
Ensembl chr 2:65,074,870...65,095,551
|
|
G |
PRKCD |
protein kinase C delta |
increases phosphorylation |
EXP |
sodium arsenite results in increased phosphorylation of PRKCD protein |
CTD |
PMID:15089098 |
|
NCBI chr13:35,290,835...35,323,245
Ensembl chr13:35,290,610...35,323,356
|
|
G |
RPS6KA1 |
ribosomal protein S6 kinase A1 |
decreases expression |
EXP |
sodium arsenite results in decreased expression of RPS6KA1 protein |
CTD |
PMID:12760830 |
|
NCBI chr 6:83,905,124...83,947,189
Ensembl chr 6:83,905,077...83,950,963
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions increases activity |
EXP |
[sodium arsenite results in increased activity of SOD1 protein] which results in increased abundance of Hydrogen Peroxide |
CTD |
PMID:12530527 |
|
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729
|
|
G |
TP53 |
tumor protein p53 |
increases expression |
EXP |
sodium arsenite results in increased expression of TP53 |
CTD |
PMID:13129816 |
|
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
|
|
G |
VEGFA |
vascular endothelial growth factor A |
increases expression multiple interactions |
EXP |
sodium arsenite results in increased expression of VEGFA mRNA bisindolylmaleimide I inhibits the reaction [sodium arsenite results in increased expression of VEGFA mRNA]; R 59949 promotes the reaction [sodium arsenite results in increased expression of VEGFA mRNA]; sodium arsenite results in increased expression of and results in increased secretion of VEGFA protein |
CTD |
PMID:15089098 |
|
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
|
|
|
G |
DAO |
D-amino acid oxidase |
decreases activity |
EXP |
Sodium Benzoate results in decreased activity of DAO protein |
CTD |
PMID:20952482 |
|
NCBI chr14:41,931,549...41,950,628
Ensembl chr14:41,931,541...41,950,633
|
|
|
G |
CCL2 |
chemokine (C-C motif) ligand 2 |
multiple interactions |
EXP |
sodium borohydride inhibits the reaction [[2,2'-azobis(2-amidinopropane) results in increased oxidation of Docosahexaenoic Acids] inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CCL2 mRNA]] |
CTD |
PMID:21130106 |
|
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
|
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
decreases expression |
EXP |
sodium bichromate results in decreased expression of AKT1 protein |
CTD |
PMID:12760830 |
|
|
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
multiple interactions |
EXP |
sodium metabisulfite inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA] |
CTD |
PMID:33817499 |
|
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
EXP |
sodium metabisulfite inhibits the reaction [deoxynivalenol results in increased expression of IL6 mRNA] |
CTD |
PMID:33817499 |
|
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
|
|
|
G |
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase |
multiple interactions |
EXP |
[Sodium Bicarbonate co-treated with Calcium Chloride] results in increased activity of GAPDH protein |
CTD |
PMID:26582256 |
|
NCBI chr 5:64,129,678...64,135,194
Ensembl chr 5:64,129,679...64,133,991
|
|
|
G |
SLC5A5 |
solute carrier family 5 member 5 |
multiple interactions increases uptake |
EXP |
sodium perchlorate inhibits the reaction [SLC5A5 protein alternative form results in increased uptake of Sodium Iodide]; sodium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide] SLC5A5 protein alternative form results in increased uptake of Sodium Iodide; SLC5A5 protein results in increased uptake of Sodium Iodide |
CTD |
PMID:12586784 |
|
NCBI chr 2:59,869,157...59,885,086
Ensembl chr 2:59,869,155...59,885,266
|
|
|
G |
SLC5A5 |
solute carrier family 5 member 5 |
multiple interactions |
EXP |
sodium perchlorate inhibits the reaction [SLC5A5 protein alternative form results in increased uptake of Sodium Iodide]; sodium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide] |
CTD |
PMID:12586784 |
|
NCBI chr 2:59,869,157...59,885,086
Ensembl chr 2:59,869,155...59,885,266
|
|
G |
TPO |
thyroid peroxidase |
decreases activity |
EXP |
sodium perchlorate results in decreased activity of TPO protein |
CTD |
PMID:23959146 |
|
NCBI chr 3:132,384,677...132,409,750
Ensembl chr 3:132,384,583...132,409,208
|
|